Molecular Loop

Thrilled to see this report, by the world-class team at Labcorp, demonstrating LoopCap’s inherent performance advantages when applied to viral surveillance! https://lnkd.in/eCMeZCBX

Excited to share that Molecular Loop will be presenting a poster at AGBT 2024! Join us for our scientific poster session on Tuesday, Feb 6 from 1:30 to 3:30 PM, where you can meet with our CSO, Eric Boyden, and learn more about our groundbreaking research and LoopCap? technology. See you there! #AGBT24 #AGBT

??? Celebrating the holidays with some friendly competition at Molecular Loop! Our festive spirit transcended borders as team members gathered around the country to mark the season. Amidst the joyous coastal meet-ups, our in-office holiday bash evolved into an exhilarating foosball tournament where Aaron Aker emerged victorious! ???? Reflecting on the year, we're grateful for our customers and our team for continually pushing the boundaries of what is possible in the world of targeted sequencing. Here's to a season of unity, progress, and exciting discoveries ahead! Happy holidays from our globally connected Molecular Loop team! ????

Molecular Loop is pleased to announce that we have received a $1.8M grant from the Bill & Melinda Gates Foundation to further our groundbreaking work in the field of multi-pathogen genomics. ?? "This grant from the foundation will support our commitment to expanding access to NGS with LoopCap? technology. LoopCap addresses challenges in sample turn-around time and dropouts due to rapid mutation – both common issues with pathogen sequencing methods today," said Greg Porreca, PhD, CEO of Molecular Loop. "We are excited to continue our mission of democratizing access to NGS technologies for all laboratories, particularly in resource-limited settings." Read the full press release here: https://bit.ly/3GCsCKy

LoopCap? technology is transforming pathogen surveillance. In our collaborative poster presentation with Labcorp at #AMPath23, we showcased how our innovative pathogen target enrichment approach enabled the deposit of hundreds of thousands of viral genomes into GISAID without requiring panel updates post-validation. Learn more about how LoopCap has maintained its performance, even in the face of rapidly mutating genomes here: https://bit.ly/46RH6AF #publichealth #epidemiology